Jiang, Minghuan <br/><br/>
Cost-effectiveness analysis of 30-month vs 12-month dual antiplatelet therapy with clopidogrel and aspirin after drug-eluting stents in patients with acute coronary syndrome.  [electronic resource] 

 -  Clinical cardiology  Oct 2017 
 - 789-796 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1932-8737 
<br/><br/><label>Standard No.: </label>10.1002/clc.22756  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Coronary Syndrome--diagnosis<br/>Aspirin--administration & dosage<br/>Clopidogrel<br/>Computer Simulation<br/>Coronary Thrombosis--economics<br/>Cost-Benefit Analysis<br/>Decision Trees<br/>Disease-Free Survival<br/>Drug Administration Schedule<br/>Drug Costs<br/>Drug Therapy, Combination<br/>Drug-Eluting Stents--economics<br/>Hemorrhage--chemically induced<br/>Humans<br/>Middle Aged<br/>Models, Economic<br/>Monte Carlo Method<br/>Myocardial Infarction--economics<br/>Odds Ratio<br/>Percutaneous Coronary Intervention--adverse effects<br/>Platelet Aggregation Inhibitors--administration & dosage<br/>Quality-Adjusted Life Years<br/>Risk Factors<br/>Stroke--economics<br/>Ticlopidine--administration & dosage<br/>Time Factors<br/>Treatment Outcome